6 results match your criteria: "Yale University School ofMedicine[Affiliation]"
Clin Lymphoma Myeloma Leuk
September 2022
Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA. Electronic address:
Introduction: Peripheral T-Cell Lymphomas (PTCL) are a rare subgroup of lymphomas with a poor outcome.Traditional prognostic measures rely heavily on disease stage, and with the advent of targeted treatment, further stratificationcriteria are needed to guide treatment. To date, the impact of blood involvement at diagnosis on outcomes has not been assessed.
View Article and Find Full Text PDFJ Biol Chem
July 2011
Department of Pharmacology, Yale University School ofMedicine, New Haven, Connecticut 06520, USA.
Cerebral cavernous malformation (CCM) is a disease that affects between 0.1 and 0.5% of the human population, with mutations in CCM3 accounting for ~ 15% of the autosomal dominant form of the disease.
View Article and Find Full Text PDFDiabetes Care
May 2011
Section of Palliative Care, Department of Medicine, Yale University School ofMedicine, New Haven, Connecticut, USA.
Objective: Functional cobalamin (Cbl) deficiency (i.e., high methylmalonic acid [MMA] values despite normal serum Cbl levels) is common in the elderly and associated with neuropathy and anemia.
View Article and Find Full Text PDFClin J Am Soc Nephrol
December 2009
Department of Medicine, Hospital of Saint Raphael, Yale University School ofMedicine, 1450 Chapel Street, New Haven, CT 06511, USA.
Clinical outcomes have not improved substantially for patients treated with conventional thrice weekly hemodialysis. More intensive hemodialysis regimens, including daily short dialysis, and nocturnal prolonged dialysis show promise to improve morbidity and mortality. Published studies and trials underway examining these therapies are reviewed.
View Article and Find Full Text PDFPsychother Res
March 2009
Department of Psychiatry, Yale University School ofMedicine, VA Connecticut Healthcare System, 950 Campbell Avenue (151-D),West Haven, CT 06516, USA.
This study examined the correspondence of treatment integrity ratings (adherence and competence) among community program therapists, supervisors, and observers for therapists who used motivational enhancement therapy (MET) within a National Institute on Drug Abuse Clinical Trials Network protocol. The results suggested there was reasonable agreement between the three groups of raters about the presence or absence of several fundamental MET strategies. Moreover, relative to observers, therapists and supervisors were more positive in their evaluations of the therapists' MET adherence and competence.
View Article and Find Full Text PDFJ Am Geriatr Soc
May 2003
Department of Internal Medicine, Yale University School ofMedicine, New Haven, Connecticut 06520, USA.
Objectives: To determine the prevalence of preexisting cognitive impairment (CI) in patients admitted to the medical intensive care unit (ICU) and compare two different proxy measures of preexisting CI in ICU patients.
Design: Cross-sectional comparative study.
Setting: Urban university teaching hospital.